LONDON, April 15 (Reuters) - The world's first genetic test to assess the risk of individuals developing type 2 diabetes has been launched by Iceland's Decode Genetics Inc. . The biotech company, ...
The study is part of the PsychENCODE Consortium, which brings together multidisciplinary teams to generate large-scale gene expression and regulatory data from human brains across several major ...
SAN FRANCISCO, California, USA, 8 July 2025 – In a comprehensive Genomic Press Interview published in Brain Medicine, Dr. Michael C. Oldham shares his unconventional journey from advertising executive ...
Researchers have investigated how cationic polymers organize on a molecular level when transporting RNA drugs. LMU researchers have investigated how cationic polymers organize on a molecular level ...
CRISPR will get easier and easier to administer. What does that mean for the future of our species? In 2016, I attended a large meeting of journalists in Washington, DC. The keynote speaker was ...
Preliminary results from a small trial offer the clearest evidence yet that the brain disease’s progression can be slowed. A one-time gene therapy can markedly slow the progression of Huntington’s ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback